- Psychiatric Times Vol 14 No 6
- Volume 14
- Issue 6
Health Care Mutual Funds
One type of investment that psychiatrists might find especially intriguing are health care mutual funds-specialized portfolios that invest in medical companies ranging from pharmaceutical manufacturers to biotechnology firms to health maintenance organizations. Although these industry-specific funds should not be held in isolation, they can provide solid long-term growth potential to a well-diversified portfolio. Here's key information on five top funds:
One type of investment that psychiatrists might find especially intriguing are health care mutual funds-specialized portfolios that invest in medical companies ranging from pharmaceutical manufacturers to biotechnology firms to health maintenance organizations. Although these industry-specific funds should not be held in isolation, they can provide solid long-term growth potential to a well-diversified portfolio. Here's key information on five top funds:
- Fund Name
- Sales Charge/Load
- Phone
- Average Annual Return*
- MinimumEaton Vance Traditional Worldwide Health Sciences
4.7%
800-225-6265
+17.98%
$1,000
- Vanguard Specialized Health Care
None
800-662-7447
+17.81%
$3,000
- Fidelity Select Health Care
3%
800-544-8888
+13.64 percent
$2,500Putnam Health Sciences
5.75%
800-225-1581
+13.50 percent
$500
- T. Rowe Price Health Sciences
None
800-638-5660
N.A.**
$2,500
Notes: Performance results are average annualized figures for the five years through Jan. 31, 1997, as provided by Morningstar Inc. of Chicago. The T. Rowe Price fund debuted in December 1995.
Articles in this issue
about 29 years ago
Psychoanalysis and Pharmacotherapy - Incompatible or Synergistic?about 29 years ago
Psychiatrist Finds Niche in Clinical Trials Testingabout 29 years ago
EEOC Issues ADA Guidelines for Mentally Disabledabout 29 years ago
More and More Physicians Forming Independent Investigator Sitesabout 29 years ago
Violence and Survival: Denial and the Ultimate Threatabout 29 years ago
Algorithm Project Takes Shape in Texasabout 29 years ago
Current Obstacles to Drug Developmentabout 29 years ago
Vitamin E for Alzheimer's Report Cautiously Interpreted






